Given that IL-15 activates and enhances the survival of CD8 T cells and NK cells, anti-prostate stem cell antigen (PSCA) CAR-NK cells engineered with a soluble IL-15 have demonstrated the capability to suppress tumor progression and prolong survival in a mouse model of metastatic pancreatic cancer [225]. The gene discussed is IL15; the disease is neoplasm.